% | $
Quotes you view appear here for quick access.

Array BioPharma Inc. Message Board

  • naked_finger naked_finger Feb 13, 2013 12:09 PM Flag

    end of the year

    Sec IPO in July and it will be priced cheap because of delays ...

    1. Talked towards the beginning of the presentation of partnering ARRY-520 and/or ARRY-614 geographically (offered possibility of ex-U.S. partnering before). Not sure if this means increased discussions on this front. Conversely, ARRY-797 partnering timing seems to have been pushed back as I believe the guidance now was just "by the end of the year" whereas previously there seemed to be guidance for mid-2013.

    2. Have hit MTD on ARRY-614 and will move into expansion cohort at the selected dose in a "refined target population." Not really made clear what is meant by "refined target population." Also, sounds like will have data to inform potential Phase 3 trial design by the end of this year. Seems like timing for 614 program has been pushed back a bit as I thought previously the expectation was to have the key data in mid-2013.

    Sentiment: Sell

    SortNewest  |  Oldest  |  Most Replied Expand all replies
4.96-0.02(-0.40%)Oct 8 4:00 PMEDT